Literature DB >> 9541008

Expression of SNARE proteins in enteroendocrine cell lines and functional role of tetanus toxin-sensitive proteins in cholecystokinin release.

E Némoz-Gaillard1, A Bosshard, R Regazzi, C Bernard, J C Cuber, M Takahashi, S Catsicas, J A Chayvialle, J Abello.   

Abstract

In neurons, synaptic vesicle exocytosis involves the formation of a core complex particle including syntaxin-1, synaptosomal-associated protein of 25 kDa (SNAP-25) and vesicle-associated membrane protein (VAMP)-2/synaptobrevin. The expression of these proteins was investigated in a panel of cell lines, including lines of endocrine and intestinal origin, by Western blotting and/or immunocytochemistry. The three core complex proteins were detected in the enteroendocrine, cholecystokinin (CCK)-secreting, cell lines STC-1 and GLUTag, and in the endocrine non-intestinal cell lines CA-77 and HIT-T15. In contrast, SNAP-25 and syntaxin-1 were undetected in the intestinal non-endocrine cell lines IEC-6, HT-29 and Caco-2, whereas a slight expression of VAMP-2 was documented in IEC-6 and HT-29 cells. Co-immunoprecipitation experiments indicated that syntaxin-1, SNAP-25 and VAMP-2 were present in a complex similar to that identified in brain. In the STC-1 cell line, treatment of streptolysin-O-permeabilized cells with tetanus toxin (Tetx) selectively cleaved VAMP-2 and VAMP-3/cellubrevin, and simultaneously abolished Ca2+-induced CCK secretion (IC50 approximately 12 nM). These results show that endocrine cell lines of intestinal origin express syntaxin-1, SNAP-25 and VAMP-2, and suggest a key role for a Tetx-sensitive protein (for example VAMP-2 and/or VAMP-3) in the CCK secretion by STC-1 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541008     DOI: 10.1016/s0014-5793(98)00209-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  A specific subset of transient receptor potential vanilloid-type channel subunits in Caenorhabditis elegans endocrine cells function as mixed heteromers to promote neurotransmitter release.

Authors:  Antony M Jose; I Amy Bany; Daniel L Chase; Michael R Koelle
Journal:  Genetics       Date:  2006-10-22       Impact factor: 4.562

2.  Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell.

Authors:  Samantha K Li; Dan Zhu; Herbert Y Gaisano; Patricia L Brubaker
Journal:  Diabetologia       Date:  2013-12-20       Impact factor: 10.122

3.  SNAP25 mutation disrupts metabolic homeostasis, steroid hormone production and central neurobehavior.

Authors:  Xiao Hao; Bing Zhu; Pinglin Yang; Dachuan Dong; Peyman Sahbaie; Peter L Oliver; Wen-Jun Shen; Salman Azhar; Fredric B Kraemer
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-11-24       Impact factor: 5.187

4.  Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis.

Authors:  Thierry Coppola; Christian Frantz; Véronique Perret-Menoud; Sonia Gattesco; Harald Hirling; Romano Regazzi
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

5.  Duodenal PKC-δ and cholecystokinin signaling axis regulates glucose production.

Authors:  Danna M Breen; Jessica T Y Yue; Brittany A Rasmussen; Andrea Kokorovic; Grace W C Cheung; Tony K T Lam
Journal:  Diabetes       Date:  2011-10-07       Impact factor: 9.461

6.  Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells.

Authors:  Rune Ehrenreich Kuhre; Nicolai Jacob Wewer Albrechtsen; Carolyn Fiona Deacon; Emilie Balk-Møller; Jens Frederik Rehfeld; Frank Reimann; Fiona Mary Gribble; Jens Juul Holst
Journal:  J Mol Endocrinol       Date:  2016-01-27       Impact factor: 5.098

7.  Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose.

Authors:  Alessandra Puddu; Roberta Sanguineti; Fabrizio Montecucco; Giorgio L Viviani
Journal:  Mediators Inflamm       Date:  2014-02-04       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.